Cerus Corporation (CERS) vs Pacific Biosciences of California, Inc. (PACB)
Cerus Corporation and Pacific Biosciences of California, Inc. are both Medical Devices companies. Cerus Corporation and Pacific Biosciences of California, Inc. are of similar size ($524.0M and $484.9M). Cerus Corporation grew revenue faster over the last twelve months: 14.6% against 2.02%. Cerus Corporation has the higher net margin (−2.73% vs −82.5%) and the higher return on invested capital (−1.27% vs −22.2%). Across the 17 metrics below, Cerus Corporation leads on 14 and Pacific Biosciences of California, Inc. on 3.
Valuation
Profitability
| Metric | CERS | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 57.16% | 36.38% | 56.01% |
| Operating margin | (0.65%) | (83.53%) | (15.03%) |
| Net margin | (2.73%) | (82.49%) | (20.40%) |
| Free cash flow margin | (0.74%) | (50.53%) | (7.24%) |
| Return on equity | (10.69%) | (929.31%) | (15.32%) |
| Return on assets | (3.24%) | (16.66%) | (19.72%) |
| Return on invested capital | (1.27%) | (22.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack